In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 40 for your search:
Cancer Type/Condition:  Breast cancer, female
Trial Type:  Treatment
Drug:  trastuzumab
Find trials that include:  Any drugs shown
Trial Status:  Closed
Trial Phase:  Phase III
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ROCHE-BO16216, CWRU-030118, GENENTECH-H2223g, ROCHE-1100, ROCHE-B016216F, NCT00022672
2.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: GEICAM/2006-14, Nº EudraCT 2007-007031-13, NCT00841828
3.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: GENENTECH-HO648G, NCI-V95-0714
4.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: UCLA-HSPC-9510492, NCI-V96-0947
5.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02792, CALGB-9840, U10CA031946, CDR0000066468, CLB-9840, NCT00003440
6.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: Other
Protocol IDs: SAKK 22/99, SWS-SAKK-22/99, EU-99028, NCT00004935
7.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01849, NCCTG-N9831, U10CA025224, CDR0000067953, CALGB-49909, ECOG-N9831, SWOG-N9831, GUMC-00224, N9831, CAN-NCIC-MA28, MA28, NCT00005970
8.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: AVENTIS-TAX-GMA-302, UCLA-0102006, BCIRG-006, UAB-0106, UAB-F010326012, NCI-G01-1978, NCT00768092
9.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: BO16348, BIG-01-01, EU-20216, ROCHE-B016348E, ROCHE-B016348C, EORTC-10011, CAN-NCIC-MA24, IBCSG-28-02, MA24, NCT00045032
10.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: NCI, Other
Protocol IDs: CDR0000257580, P30CA016042, UCLA-0109024, BCIRG-007, ROCHE-UCLA-0109024, GENENTECH-UCLA-0109024, NCI-G02-2116, NCT00047255
11.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 64
Sponsor: Other
Protocol IDs: CDR0000269909, FRE-FNCLCC-PACS-04/0005, EU-20236, NCT00054587
12.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000334899, SWOG-S0221, S0221, NCT00070564
13.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: ID99-146, NCT00038402
14.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-S0347, S0347, NCT00103233
15.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: GBG 26, BIG3-05, NCT00148876
16.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EGF104383, NCT00272987
17.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 an over
Sponsor: Pharmaceutical / Industry
Protocol IDs: STM01-102, NCT00294996
18.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EGF104900, NCT00320385
19.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000509793, INCA-PHARE, INCA-RECF0146, EUDRACT-2006-000070-67, PHARE, NCT00381901
20.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: BO20231, NCT00391092
21.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ML18742, NCT00448279
22.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: NSABP B-41, NCT00486668
23.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00341, Z1041, CDR0000559039, ACOSOG-Z1041, U10CA012027, NCT00513292
24.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00504, E1105, CDR0000561762, U10CA021115, ECOG-E1105, NCT00520975
25.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EGF106903, NCT00553358
1   
New Search